CD274 and neoplasm: In some tumors, as cancer progresses, tumor-infiltrating DC accumulate and switch from immunostimulatory to regulatory phenotypes (23), and correlates with the increased expression of negative costimulatory molecules such as TIM3 (89), PD-L1 and PD-1 (90) as well as the production of L-Arginase (91).